nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ABCB1—Mitoxantrone—lymphatic system cancer	0.0263	0.475	CbGbCtD
Atenolol—ABCB1—Vincristine—lymphatic system cancer	0.0181	0.327	CbGbCtD
Atenolol—ABCB1—Methotrexate—lymphatic system cancer	0.011	0.198	CbGbCtD
Atenolol—Hepatic enzyme increased—Mitoxantrone—lymphatic system cancer	0.00763	0.00808	CcSEcCtD
Atenolol—Sweating—Teniposide—lymphatic system cancer	0.00741	0.00784	CcSEcCtD
Atenolol—Vertigo—Mechlorethamine—lymphatic system cancer	0.00736	0.00779	CcSEcCtD
Atenolol—Disorientation—Bleomycin—lymphatic system cancer	0.00722	0.00764	CcSEcCtD
Atenolol—Renal failure—Fludarabine—lymphatic system cancer	0.00667	0.00706	CcSEcCtD
Atenolol—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00665	0.00705	CcSEcCtD
Atenolol—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00654	0.00693	CcSEcCtD
Atenolol—Flushing—Teniposide—lymphatic system cancer	0.00644	0.00681	CcSEcCtD
Atenolol—Epistaxis—Fludarabine—lymphatic system cancer	0.0064	0.00678	CcSEcCtD
Atenolol—Anorexia—Mechlorethamine—lymphatic system cancer	0.00637	0.00674	CcSEcCtD
Atenolol—Arrhythmia—Teniposide—lymphatic system cancer	0.00619	0.00656	CcSEcCtD
Atenolol—Alopecia—Teniposide—lymphatic system cancer	0.00613	0.00649	CcSEcCtD
Atenolol—Amnesia—Carmustine—lymphatic system cancer	0.006	0.00635	CcSEcCtD
Atenolol—Visual impairment—Fludarabine—lymphatic system cancer	0.00587	0.00622	CcSEcCtD
Atenolol—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00581	0.00615	CcSEcCtD
Atenolol—Cardiac failure congestive—Mitoxantrone—lymphatic system cancer	0.00578	0.00612	CcSEcCtD
Atenolol—Psoriasis—Methotrexate—lymphatic system cancer	0.00572	0.00606	CcSEcCtD
Atenolol—Bronchospasm—Bleomycin—lymphatic system cancer	0.00549	0.00581	CcSEcCtD
Atenolol—Arrhythmia—Fludarabine—lymphatic system cancer	0.00544	0.00576	CcSEcCtD
Atenolol—Alopecia—Fludarabine—lymphatic system cancer	0.00539	0.0057	CcSEcCtD
Atenolol—Pain in extremity—Vincristine—lymphatic system cancer	0.00538	0.0057	CcSEcCtD
Atenolol—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00537	0.00569	CcSEcCtD
Atenolol—Ataxia—Carmustine—lymphatic system cancer	0.0053	0.00561	CcSEcCtD
Atenolol—Chest pain—Teniposide—lymphatic system cancer	0.00514	0.00544	CcSEcCtD
Atenolol—Cardiac arrest—Vincristine—lymphatic system cancer	0.00512	0.00542	CcSEcCtD
Atenolol—Ataxia—Vincristine—lymphatic system cancer	0.00506	0.00536	CcSEcCtD
Atenolol—Confusional state—Teniposide—lymphatic system cancer	0.00497	0.00526	CcSEcCtD
Atenolol—Oedema—Teniposide—lymphatic system cancer	0.00493	0.00522	CcSEcCtD
Atenolol—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00492	0.00521	CcSEcCtD
Atenolol—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00488	0.00517	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00485	0.00513	CcSEcCtD
Atenolol—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00482	0.00511	CcSEcCtD
Atenolol—Tachycardia—Teniposide—lymphatic system cancer	0.00481	0.00509	CcSEcCtD
Atenolol—Malaise—Fludarabine—lymphatic system cancer	0.00478	0.00506	CcSEcCtD
Atenolol—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00476	0.00504	CcSEcCtD
Atenolol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00473	0.00501	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00472	0.005	CcSEcCtD
Atenolol—Anorexia—Teniposide—lymphatic system cancer	0.0047	0.00497	CcSEcCtD
Atenolol—Cough—Fludarabine—lymphatic system cancer	0.00463	0.0049	CcSEcCtD
Atenolol—Hypotension—Teniposide—lymphatic system cancer	0.0046	0.00487	CcSEcCtD
Atenolol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00457	0.00484	CcSEcCtD
Atenolol—Discomfort—Fludarabine—lymphatic system cancer	0.00446	0.00472	CcSEcCtD
Atenolol—Dyspnoea—Teniposide—lymphatic system cancer	0.00439	0.00465	CcSEcCtD
Atenolol—Confusional state—Fludarabine—lymphatic system cancer	0.00437	0.00462	CcSEcCtD
Atenolol—Depression—Carmustine—lymphatic system cancer	0.00433	0.00459	CcSEcCtD
Atenolol—Oedema—Fludarabine—lymphatic system cancer	0.00433	0.00458	CcSEcCtD
Atenolol—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00428	0.00454	CcSEcCtD
Atenolol—Decreased appetite—Teniposide—lymphatic system cancer	0.00428	0.00453	CcSEcCtD
Atenolol—Renal failure—Carmustine—lymphatic system cancer	0.00427	0.00452	CcSEcCtD
Atenolol—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00424	0.00449	CcSEcCtD
Atenolol—Rash—Mechlorethamine—lymphatic system cancer	0.00421	0.00446	CcSEcCtD
Atenolol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00421	0.00446	CcSEcCtD
Atenolol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00419	0.00443	CcSEcCtD
Atenolol—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00417	0.00442	CcSEcCtD
Atenolol—Flushing—Bleomycin—lymphatic system cancer	0.00415	0.00439	CcSEcCtD
Atenolol—Depression—Vincristine—lymphatic system cancer	0.00414	0.00438	CcSEcCtD
Atenolol—Anorexia—Fludarabine—lymphatic system cancer	0.00413	0.00437	CcSEcCtD
Atenolol—Myocardial infarction—Vincristine—lymphatic system cancer	0.00407	0.0043	CcSEcCtD
Atenolol—Feeling abnormal—Teniposide—lymphatic system cancer	0.00406	0.0043	CcSEcCtD
Atenolol—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00404	0.00428	CcSEcCtD
Atenolol—Sweating—Vincristine—lymphatic system cancer	0.00398	0.00421	CcSEcCtD
Atenolol—Renal failure—Mitoxantrone—lymphatic system cancer	0.00397	0.0042	CcSEcCtD
Atenolol—Nausea—Mechlorethamine—lymphatic system cancer	0.00397	0.0042	CcSEcCtD
Atenolol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00396	0.00419	CcSEcCtD
Atenolol—Alopecia—Bleomycin—lymphatic system cancer	0.00395	0.00418	CcSEcCtD
Atenolol—Body temperature increased—Teniposide—lymphatic system cancer	0.00389	0.00412	CcSEcCtD
Atenolol—Paraesthesia—Fludarabine—lymphatic system cancer	0.00389	0.00412	CcSEcCtD
Atenolol—Hallucination—Carmustine—lymphatic system cancer	0.00388	0.00411	CcSEcCtD
Atenolol—Sweating—Mitoxantrone—lymphatic system cancer	0.00387	0.0041	CcSEcCtD
Atenolol—Dyspnoea—Fludarabine—lymphatic system cancer	0.00386	0.00409	CcSEcCtD
Atenolol—Dyspepsia—Fludarabine—lymphatic system cancer	0.00381	0.00403	CcSEcCtD
Atenolol—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.0038	0.00403	CcSEcCtD
Atenolol—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00377	0.00399	CcSEcCtD
Atenolol—Decreased appetite—Fludarabine—lymphatic system cancer	0.00376	0.00398	CcSEcCtD
Atenolol—Visual impairment—Carmustine—lymphatic system cancer	0.00376	0.00398	CcSEcCtD
Atenolol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00374	0.00396	CcSEcCtD
Atenolol—Fatigue—Fludarabine—lymphatic system cancer	0.00373	0.00395	CcSEcCtD
Atenolol—Hallucination—Vincristine—lymphatic system cancer	0.0037	0.00392	CcSEcCtD
Atenolol—Pain—Fludarabine—lymphatic system cancer	0.0037	0.00392	CcSEcCtD
Atenolol—Constipation—Fludarabine—lymphatic system cancer	0.0037	0.00392	CcSEcCtD
Atenolol—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00369	0.00391	CcSEcCtD
Atenolol—Flushing—Carmustine—lymphatic system cancer	0.00362	0.00383	CcSEcCtD
Atenolol—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00361	0.00382	CcSEcCtD
Atenolol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00357	0.00378	CcSEcCtD
Atenolol—Asthenia—Teniposide—lymphatic system cancer	0.00353	0.00374	CcSEcCtD
Atenolol—Malaise—Bleomycin—lymphatic system cancer	0.00351	0.00371	CcSEcCtD
Atenolol—Pruritus—Teniposide—lymphatic system cancer	0.00349	0.00369	CcSEcCtD
Atenolol—Arrhythmia—Carmustine—lymphatic system cancer	0.00348	0.00369	CcSEcCtD
Atenolol—Alopecia—Carmustine—lymphatic system cancer	0.00345	0.00365	CcSEcCtD
Atenolol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00342	0.00362	CcSEcCtD
Atenolol—Cough—Bleomycin—lymphatic system cancer	0.00339	0.00359	CcSEcCtD
Atenolol—Diarrhoea—Teniposide—lymphatic system cancer	0.00337	0.00357	CcSEcCtD
Atenolol—Chest pain—Bleomycin—lymphatic system cancer	0.00331	0.00351	CcSEcCtD
Atenolol—Alopecia—Vincristine—lymphatic system cancer	0.00329	0.00348	CcSEcCtD
Atenolol—Discomfort—Bleomycin—lymphatic system cancer	0.00327	0.00346	CcSEcCtD
Atenolol—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00324	0.00343	CcSEcCtD
Atenolol—Alopecia—Mitoxantrone—lymphatic system cancer	0.0032	0.00339	CcSEcCtD
Atenolol—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.0032	0.00339	CcSEcCtD
Atenolol—Confusional state—Bleomycin—lymphatic system cancer	0.0032	0.00339	CcSEcCtD
Atenolol—Vision blurred—Carmustine—lymphatic system cancer	0.0032	0.00339	CcSEcCtD
Atenolol—Oedema—Bleomycin—lymphatic system cancer	0.00317	0.00336	CcSEcCtD
Atenolol—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00311	0.00329	CcSEcCtD
Atenolol—Asthenia—Fludarabine—lymphatic system cancer	0.00311	0.00329	CcSEcCtD
Atenolol—Rash—Teniposide—lymphatic system cancer	0.00311	0.00329	CcSEcCtD
Atenolol—Dermatitis—Teniposide—lymphatic system cancer	0.0031	0.00329	CcSEcCtD
Atenolol—Headache—Teniposide—lymphatic system cancer	0.00309	0.00327	CcSEcCtD
Atenolol—Pruritus—Fludarabine—lymphatic system cancer	0.00306	0.00324	CcSEcCtD
Atenolol—Anorexia—Bleomycin—lymphatic system cancer	0.00303	0.0032	CcSEcCtD
Atenolol—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00297	0.00315	CcSEcCtD
Atenolol—Hypotension—Bleomycin—lymphatic system cancer	0.00297	0.00314	CcSEcCtD
Atenolol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00296	0.00314	CcSEcCtD
Atenolol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00293	0.0031	CcSEcCtD
Atenolol—Nausea—Teniposide—lymphatic system cancer	0.00293	0.0031	CcSEcCtD
Atenolol—Vertigo—Vincristine—lymphatic system cancer	0.00291	0.00308	CcSEcCtD
Atenolol—Chest pain—Carmustine—lymphatic system cancer	0.00289	0.00306	CcSEcCtD
Atenolol—Anxiety—Carmustine—lymphatic system cancer	0.00288	0.00305	CcSEcCtD
Atenolol—Paraesthesia—Bleomycin—lymphatic system cancer	0.00285	0.00302	CcSEcCtD
Atenolol—Malaise—Mitoxantrone—lymphatic system cancer	0.00285	0.00301	CcSEcCtD
Atenolol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00283	0.003	CcSEcCtD
Atenolol—Confusional state—Carmustine—lymphatic system cancer	0.00279	0.00296	CcSEcCtD
Atenolol—Oedema—Carmustine—lymphatic system cancer	0.00277	0.00293	CcSEcCtD
Atenolol—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00277	0.00293	CcSEcCtD
Atenolol—Decreased appetite—Bleomycin—lymphatic system cancer	0.00276	0.00292	CcSEcCtD
Atenolol—Visual disturbance—Methotrexate—lymphatic system cancer	0.00276	0.00292	CcSEcCtD
Atenolol—Cough—Mitoxantrone—lymphatic system cancer	0.00275	0.00292	CcSEcCtD
Atenolol—Rash—Fludarabine—lymphatic system cancer	0.00273	0.00289	CcSEcCtD
Atenolol—Dermatitis—Fludarabine—lymphatic system cancer	0.00273	0.00289	CcSEcCtD
Atenolol—Pain—Bleomycin—lymphatic system cancer	0.00271	0.00287	CcSEcCtD
Atenolol—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00271	0.00287	CcSEcCtD
Atenolol—Headache—Fludarabine—lymphatic system cancer	0.00271	0.00287	CcSEcCtD
Atenolol—Tachycardia—Carmustine—lymphatic system cancer	0.0027	0.00286	CcSEcCtD
Atenolol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00269	0.00285	CcSEcCtD
Atenolol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00268	0.00284	CcSEcCtD
Atenolol—Lethargy—Methotrexate—lymphatic system cancer	0.00266	0.00282	CcSEcCtD
Atenolol—Discomfort—Mitoxantrone—lymphatic system cancer	0.00266	0.00281	CcSEcCtD
Atenolol—Oedema—Vincristine—lymphatic system cancer	0.00265	0.0028	CcSEcCtD
Atenolol—Anorexia—Carmustine—lymphatic system cancer	0.00264	0.0028	CcSEcCtD
Atenolol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00262	0.00277	CcSEcCtD
Atenolol—Confusional state—Mitoxantrone—lymphatic system cancer	0.0026	0.00275	CcSEcCtD
Atenolol—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00259	0.00274	CcSEcCtD
Atenolol—Hypotension—Carmustine—lymphatic system cancer	0.00259	0.00274	CcSEcCtD
Atenolol—Oedema—Mitoxantrone—lymphatic system cancer	0.00258	0.00273	CcSEcCtD
Atenolol—Nausea—Fludarabine—lymphatic system cancer	0.00257	0.00272	CcSEcCtD
Atenolol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00256	0.00271	CcSEcCtD
Atenolol—Shock—Mitoxantrone—lymphatic system cancer	0.00253	0.00268	CcSEcCtD
Atenolol—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00252	0.00267	CcSEcCtD
Atenolol—Anorexia—Vincristine—lymphatic system cancer	0.00252	0.00267	CcSEcCtD
Atenolol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00251	0.00266	CcSEcCtD
Atenolol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00251	0.00266	CcSEcCtD
Atenolol—Insomnia—Carmustine—lymphatic system cancer	0.00251	0.00265	CcSEcCtD
Atenolol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00249	0.00264	CcSEcCtD
Atenolol—Paraesthesia—Carmustine—lymphatic system cancer	0.00249	0.00263	CcSEcCtD
Atenolol—Mood swings—Methotrexate—lymphatic system cancer	0.00247	0.00262	CcSEcCtD
Atenolol—Hypotension—Vincristine—lymphatic system cancer	0.00247	0.00262	CcSEcCtD
Atenolol—Dyspnoea—Carmustine—lymphatic system cancer	0.00247	0.00262	CcSEcCtD
Atenolol—Somnolence—Carmustine—lymphatic system cancer	0.00246	0.00261	CcSEcCtD
Atenolol—Anorexia—Mitoxantrone—lymphatic system cancer	0.00246	0.0026	CcSEcCtD
Atenolol—Ataxia—Methotrexate—lymphatic system cancer	0.00246	0.0026	CcSEcCtD
Atenolol—Decreased appetite—Carmustine—lymphatic system cancer	0.00241	0.00255	CcSEcCtD
Atenolol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00241	0.00255	CcSEcCtD
Atenolol—Insomnia—Vincristine—lymphatic system cancer	0.00239	0.00253	CcSEcCtD
Atenolol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00239	0.00253	CcSEcCtD
Atenolol—Paraesthesia—Vincristine—lymphatic system cancer	0.00238	0.00251	CcSEcCtD
Atenolol—Pain—Carmustine—lymphatic system cancer	0.00237	0.00251	CcSEcCtD
Atenolol—Constipation—Carmustine—lymphatic system cancer	0.00237	0.00251	CcSEcCtD
Atenolol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00231	0.00245	CcSEcCtD
Atenolol—Decreased appetite—Vincristine—lymphatic system cancer	0.0023	0.00243	CcSEcCtD
Atenolol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.0023	0.00243	CcSEcCtD
Atenolol—Somnolence—Mitoxantrone—lymphatic system cancer	0.00229	0.00242	CcSEcCtD
Atenolol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00228	0.00242	CcSEcCtD
Atenolol—Feeling abnormal—Carmustine—lymphatic system cancer	0.00228	0.00242	CcSEcCtD
Atenolol—Fatigue—Vincristine—lymphatic system cancer	0.00228	0.00241	CcSEcCtD
Atenolol—Asthenia—Bleomycin—lymphatic system cancer	0.00228	0.00241	CcSEcCtD
Atenolol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00227	0.0024	CcSEcCtD
Atenolol—Constipation—Vincristine—lymphatic system cancer	0.00226	0.00239	CcSEcCtD
Atenolol—Pain—Vincristine—lymphatic system cancer	0.00226	0.00239	CcSEcCtD
Atenolol—Pruritus—Bleomycin—lymphatic system cancer	0.00225	0.00238	CcSEcCtD
Atenolol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00224	0.00237	CcSEcCtD
Atenolol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00222	0.00235	CcSEcCtD
Atenolol—Pain—Mitoxantrone—lymphatic system cancer	0.0022	0.00233	CcSEcCtD
Atenolol—Constipation—Mitoxantrone—lymphatic system cancer	0.0022	0.00233	CcSEcCtD
Atenolol—Body temperature increased—Carmustine—lymphatic system cancer	0.00219	0.00232	CcSEcCtD
Atenolol—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00216	0.00229	CcSEcCtD
Atenolol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00212	0.00225	CcSEcCtD
Atenolol—Body temperature increased—Vincristine—lymphatic system cancer	0.00209	0.00221	CcSEcCtD
Atenolol—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00208	0.0022	CcSEcCtD
Atenolol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00204	0.00216	CcSEcCtD
Atenolol—Drowsiness—Methotrexate—lymphatic system cancer	0.00201	0.00213	CcSEcCtD
Atenolol—Depression—Methotrexate—lymphatic system cancer	0.00201	0.00212	CcSEcCtD
Atenolol—Rash—Bleomycin—lymphatic system cancer	0.002	0.00212	CcSEcCtD
Atenolol—Dermatitis—Bleomycin—lymphatic system cancer	0.002	0.00212	CcSEcCtD
Atenolol—Asthenia—Carmustine—lymphatic system cancer	0.00199	0.0021	CcSEcCtD
Atenolol—Renal failure—Methotrexate—lymphatic system cancer	0.00198	0.00209	CcSEcCtD
Atenolol—Sweating—Methotrexate—lymphatic system cancer	0.00193	0.00204	CcSEcCtD
Atenolol—Epistaxis—Methotrexate—lymphatic system cancer	0.0019	0.00201	CcSEcCtD
Atenolol—Asthenia—Vincristine—lymphatic system cancer	0.0019	0.00201	CcSEcCtD
Atenolol—Diarrhoea—Carmustine—lymphatic system cancer	0.0019	0.00201	CcSEcCtD
Atenolol—Nausea—Bleomycin—lymphatic system cancer	0.00189	0.002	CcSEcCtD
Atenolol—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00188	0.00199	CcSEcCtD
Atenolol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00185	0.00196	CcSEcCtD
Atenolol—Dizziness—Carmustine—lymphatic system cancer	0.00183	0.00194	CcSEcCtD
Atenolol—Diarrhoea—Vincristine—lymphatic system cancer	0.00181	0.00192	CcSEcCtD
Atenolol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00176	0.00187	CcSEcCtD
Atenolol—Dizziness—Vincristine—lymphatic system cancer	0.00175	0.00185	CcSEcCtD
Atenolol—Rash—Carmustine—lymphatic system cancer	0.00175	0.00185	CcSEcCtD
Atenolol—Dermatitis—Carmustine—lymphatic system cancer	0.00175	0.00185	CcSEcCtD
Atenolol—Visual impairment—Methotrexate—lymphatic system cancer	0.00174	0.00184	CcSEcCtD
Atenolol—Headache—Carmustine—lymphatic system cancer	0.00174	0.00184	CcSEcCtD
Atenolol—Tinnitus—Methotrexate—lymphatic system cancer	0.00168	0.00178	CcSEcCtD
Atenolol—Rash—Vincristine—lymphatic system cancer	0.00167	0.00177	CcSEcCtD
Atenolol—Dermatitis—Vincristine—lymphatic system cancer	0.00167	0.00176	CcSEcCtD
Atenolol—Headache—Vincristine—lymphatic system cancer	0.00166	0.00175	CcSEcCtD
Atenolol—Nausea—Carmustine—lymphatic system cancer	0.00165	0.00174	CcSEcCtD
Atenolol—Rash—Mitoxantrone—lymphatic system cancer	0.00162	0.00172	CcSEcCtD
Atenolol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00162	0.00172	CcSEcCtD
Atenolol—Headache—Mitoxantrone—lymphatic system cancer	0.00161	0.00171	CcSEcCtD
Atenolol—Alopecia—Methotrexate—lymphatic system cancer	0.0016	0.00169	CcSEcCtD
Atenolol—Nausea—Vincristine—lymphatic system cancer	0.00157	0.00166	CcSEcCtD
Atenolol—Nausea—Mitoxantrone—lymphatic system cancer	0.00153	0.00162	CcSEcCtD
Atenolol—Vision blurred—Methotrexate—lymphatic system cancer	0.00148	0.00157	CcSEcCtD
Atenolol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00146	0.00154	CcSEcCtD
Atenolol—Malaise—Methotrexate—lymphatic system cancer	0.00142	0.0015	CcSEcCtD
Atenolol—Vertigo—Methotrexate—lymphatic system cancer	0.00141	0.0015	CcSEcCtD
Atenolol—Cough—Methotrexate—lymphatic system cancer	0.00137	0.00145	CcSEcCtD
Atenolol—Chest pain—Methotrexate—lymphatic system cancer	0.00134	0.00142	CcSEcCtD
Atenolol—Discomfort—Methotrexate—lymphatic system cancer	0.00132	0.0014	CcSEcCtD
Atenolol—Confusional state—Methotrexate—lymphatic system cancer	0.00129	0.00137	CcSEcCtD
Atenolol—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00126	0.00133	CcSEcCtD
Atenolol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00124	0.00131	CcSEcCtD
Atenolol—Anorexia—Methotrexate—lymphatic system cancer	0.00122	0.0013	CcSEcCtD
Atenolol—Hypotension—Methotrexate—lymphatic system cancer	0.0012	0.00127	CcSEcCtD
Atenolol—Insomnia—Methotrexate—lymphatic system cancer	0.00116	0.00123	CcSEcCtD
Atenolol—Paraesthesia—Methotrexate—lymphatic system cancer	0.00115	0.00122	CcSEcCtD
Atenolol—Dyspnoea—Methotrexate—lymphatic system cancer	0.00114	0.00121	CcSEcCtD
Atenolol—Somnolence—Methotrexate—lymphatic system cancer	0.00114	0.00121	CcSEcCtD
Atenolol—Dyspepsia—Methotrexate—lymphatic system cancer	0.00113	0.0012	CcSEcCtD
Atenolol—Decreased appetite—Methotrexate—lymphatic system cancer	0.00112	0.00118	CcSEcCtD
Atenolol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00111	0.00117	CcSEcCtD
Atenolol—Fatigue—Methotrexate—lymphatic system cancer	0.00111	0.00117	CcSEcCtD
Atenolol—Pain—Methotrexate—lymphatic system cancer	0.0011	0.00116	CcSEcCtD
Atenolol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00106	0.00112	CcSEcCtD
Atenolol—Body temperature increased—Methotrexate—lymphatic system cancer	0.00101	0.00107	CcSEcCtD
Atenolol—Asthenia—Methotrexate—lymphatic system cancer	0.000921	0.000975	CcSEcCtD
Atenolol—Pruritus—Methotrexate—lymphatic system cancer	0.000908	0.000961	CcSEcCtD
Atenolol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000878	0.00093	CcSEcCtD
Atenolol—Dizziness—Methotrexate—lymphatic system cancer	0.000849	0.000899	CcSEcCtD
Atenolol—Rash—Methotrexate—lymphatic system cancer	0.000809	0.000857	CcSEcCtD
Atenolol—Dermatitis—Methotrexate—lymphatic system cancer	0.000809	0.000856	CcSEcCtD
Atenolol—Headache—Methotrexate—lymphatic system cancer	0.000804	0.000851	CcSEcCtD
Atenolol—Nausea—Methotrexate—lymphatic system cancer	0.000762	0.000807	CcSEcCtD
